In TCGA‐BLCA cohort, DEGs between high/low BCAT2 groups, high/low immune score groups and high/low stromal score groups were identified and took intersection (Figure S13A, Supporting Information). This evidence concerns the gene BCAT2 and bladder transitional cell carcinoma.